Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1132-1138

  Akers, Kevin S ^a   Chaney, Chris ^a   Barsoumian, Alice ^a   Beckius, Miriam ^a   Zera, Wendy ^a,c   Yu, Xin ^a   Guymon, Charles ^b   Keen III, Edward F ^a   Robinson, Brian J ^a   Mende, Katrin ^a,c   Murray, Clinton K ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE MODIFYING ENZYME; ENZYME; GENTAMICIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACCURACY; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; GENE; GENETIC CODE; GENOTYPE ENVIRONMENT INTERACTION; HOSPITAL PHARMACY; INTENSIVE CARE UNIT; MEDICAL RECORD; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ADULT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DIAGNOSTIC ERRORS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; YOUNG ADULT;

ACINETOBACTER BAUMANNII; BACILLI (CLASS); NEGIBACTERIA;

EID: 77950462079     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02006-09     Document Type: Article

References (38)

1. Akers, K. S., K. Mende, H. C. Yun, D. R. Hospenthal, M. L. Beckius, X. Yu, and C. K. Murray. 2009. Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital. Antimicrob. Agents Chemother. S3: 2693-2695.
2. Becton Dickinson and Co. 2008. Package insert. NMIC/ID-123 panel, refer-ence no. 448723. Becton Dickinson and Co., Franklin Lakes, NJ.
3. bioMérieux. 2008. Package insert. AST-GN25 Gram-negative susceptibility card, reference no. 22230. bioMérieux, Durham, NC.
4. Boehr, D. D., K. A. Draker, K. Koteva, M. Bains, R. E. Hancock, and G. D. Wright. 2003. Broad-spectrum peptide inhibitors of aminoglycoside antibi-otic resistance enzymes. Chem. Biol. 10:189-190.
5. Boehr, D. D., I. F. Moore, and G. D. Wright. 2005. Aminoglycoside resistance mechanisms, p. 85-100. In Frontiers in antimicrobial resistance: a tribute to Stuart B. Levy. ASM Press, Washington, DC.
6. Boucher, H. W., G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheid, B. Spellberg, and J. Bartlett. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48: 1-12.
7. Buisson, Y., G. Tran Van Nhieu, L. Ginot, P. Bouvet, H. Schill, L. Driot, and M. Meyran. 1990. Nosocomial outbreaks due to amikacin-resistant tobramy-cin-sensitive Acinetobacter species: correlation with amikacin usage. J. Hosp. Infect. 15: 83-93.
8. CDC. 2009. PulseNet protocols. CDC, Atlanta, GA. http://www.cdc.gov /PULSENET/protocols.htm. Accessed September 28, 2009.
9. Cho, Y. J., D. C. Moon, J. S. Jin, C. H. Choi, Y. C. Lee, and J. C. Lee. 2009. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn. Microbiol. Infect. Dis. 64: 185-190.
10. Davies, J., and G. D. Wright. 1997. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5: 234-240.
11. Dellit, T. H., R. C. Owens, J. E. McGowan, Jr., D. N. Gerding, R. A. Weinstein, J. P. Burke, W. C. Huskins, D. L. Paterson, N. O. Fishman, C. F. Carpenter, P. J. Brennan, M. Billeter, and T. M. Hooton. 2007. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44: 159-177.
12. Eliopoulos, G. M., and Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters: approved guideline, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Gales, A. C, A. O. Reis, and R. N. Jones. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and Colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39: 183-190.
14. Gates, C. A., and D. B. Northrop. 1988. Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2"-I. Biochemistry 27: 3820-3825.
15. Gilad, J., and D. Schwartz. 2008. Need for verification of imipenem (IPM), meropenem (MER) and amikacin (AK) VITEK-2 susceptibility results for Acinetobacter baumannii (Ab)?, abstr. D-284. Abstr. 46th Meet. Infect. Dis. Soc. Am.
16. Hsieh, W. S., L. L. Sung, K. C. Tsai, and H. T. Ho. 2009. Evaluation of the VITEK 2 cards for identification and antimicrobial susceptibility testing of non-glucose-fermenting Gram-negative bacilli. APMIS 117: 241-247.
17. Joyanes, P., M. del Carmen Conejo, L. Martinez-Martinez, and E. J. Perea. 2001. Evaluation of the VITEK. 2 system for the identification and suscep-tibility testing of three species of nonfermenting gram-negative rods fre-quently isolated from clinical samples. J. Clin. Microbiol. 39: 3247-3253.
18. Jung, S. K., J. K. Yu, K. G. Park, K. Han, Y. J. Park, S. Y. Kim, and Y. Arakawa. 2009. False susceptibility to amikacin by VITEK 2 in Acinetobacter baumannii harbouring armA, abstr. P-813. Abstr. 19th Eur. Congr. Clin. Microbiol. Infect. Dis.
19. 19. Lambert, T., G. Gerbaud, and P. Courvalin. 1994. Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii. Antimicrob. Agents Chemother. 38: 1883-1889. (Pubitemid 24278774)
20. Levine, J. F., M. J. Maslow, R. E. Leibowitz, A. A. Pollock, B. A. Hanna, S. Schaefler, M. S. Simberkoff, and J. J. Rahal, Jr. 1985. Amikacm-resistant gramnegative bacilli: correlation of occurrence with amikacin use. J. Infect. Dis. 151: 295-300.
21. Ling, T. K., Z. K. Liu, and A. F. Cheng. 2003. Evaluation of the VITEK 2 system for rapid direct Identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 41: 4705-4707.
22. Ling, T. K., P. C. Tarn, Z. K. Liu, and A. F. Cheng. 2001. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J. Clin. Microbiol. 39: 2964-2966.
23. Lo-Ten-Foe, J. R., A. M. de Smet, B. M. Diederen, J. A. Kluytmans, and P. H. van Keulen. 2007. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for Colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 51: 3726-3730.
24. Menozzi, M. G., U. Eigner, S. Covan, S. Rossi, P. Somenzi, G. Dettori, C. Chezzi, and A. M. Fahr. 2006. Two-center collaborative evaluation of per-formance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria. J. Clin. Microbiol. 44: 4085-4094.
25. Miller, G. H., F. J. Sabatelli, L. Napes, R. S. Hare, and K. J. Shaw. 1995. The most frequently occurring aminoglycoside resistance mechanisms-com-bined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. J. Chemother. 7(Suppl. 2): 17-30.
26. Miller, G. H., F. J. Sabatelli, R. S. Hare, Y. Glupczynski, P. Mackey, D. Shlaes, K. Shimizu, and K. J. Shaw. 1997. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin. Infect. Dis. 24(Suppl. 1): S46-S62.
27. Noppe-Leclercq, L, F. Wallet, S. Haentjens, R. Courcol, and M. Simonet. 1999. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res. Microbiol. 150: 317-322.
28. Scott, P., G. Deye, A. Srinivasan, C. Murray, K. Moran, E. Hulten, J. Fishbain, D. Craft, S. Riddell, L. Lindler, J. Mancuso, E. Milstrey, C. T. Bautista, J. Patel, A. Ewell, T. Hamilton, C. Gaddy, M. Tenney, G. Chris-topher, K. Petersen, T. Endy, and B. Petruccelli. 2007. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in. Iraq. Clin. Infect. Dis. 44: 1577-1584.
29. Siemens. 2008. MicroScan dried Gram-negative procedure manual, refer-ence no. 3251-0510A. Siemens, Deerfield, IL.
30. Siregar, J. J., K. Miroshnikov, and S. Mobashery. 1995. Purification, char-acterization, and investigation of the mechanism of aminoglycoside 3'-phos-photransferase type Ia. Biochemistry 34: 12681-12688.
31. Snyder, J. W., G. K. Munier, and C. L. Johnson. 2008. Direct comparison of the BD Phoenix system with the MicroScan Walk Away system, for identifi-cation and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms. J. Clin. Microbiol. 46: 2327-2333.
32. Tenover, F. C, R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33: 2233-2239.
33. OXZ-51-like carbapenemase gene intrinsic to this species. J. Clin. Micro-biol. 44: 2974-2976.
34. Vaneechoutte, M., L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. de Vos, G. Claeys, and G. Verschraegen. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33: 11-15.
35. Watts, J. L., and Clinical and Laboratory Standards Institute. 2008. Devel-opment of in vitro susceptibility testing criteria and quality control param-eters for veterinary antimicrobial agents: approved guideline, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
36. Wikler, M. A., and Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aer-obically: approved standard, 8th ed. Clinical and Laboratory Standards In-stitute, Wayne, PA.
37. Wikler, M. A., and Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests: approved standard, 10th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
38. Wright, G. D. ?. Aminoglycoside-modifying enzymes. Curr. Opin. Micro-biol. 2: 499-503.